Post by
RetailRube on Mar 02, 2015 12:15pm
Why is the stock so low?
My theory is we got new managment, but now we need new shareholders. When most of the institutional investors exited, their shares were bought by mostly Canadian retail investors. But we are now fully invested and cannot buy any more shares, no matter how cheap it gets. $50m invested by Canadian retail investors in a biotech stock is a heavy burden. However, once we get wider awareness in US market and Canadian institutions focus on our story, we will get more people buying shares. Then the stock price will go back up.
My target is US $4/share on takeover. (That is Cdn $5/share.) If we just do a partnership deal with some cash injected, then we will run the US launch ourselves, receive the revenue and it will be worth $20/share about 4 years from now.
So 30 cents (US $0.24) is a goofy price.